Sucro Ltd. (SUGR.V)
9.57
0.00 (0.00%)
CAD |
TSXV |
Aug 25, 16:00
Sucro Enterprise Value : 639.78M for Aug. 25, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 25, 2026 | 639.78M |
| August 24, 2026 | 639.78M |
| August 21, 2026 | 639.78M |
| August 20, 2026 | 639.78M |
| August 19, 2026 | 640.89M |
| August 18, 2026 | 649.44M |
| August 17, 2026 | 648.44M |
| August 14, 2026 | 644.55M |
| August 13, 2026 | 644.66M |
| August 12, 2026 | 634.12M |
| August 11, 2026 | 639.00M |
| August 10, 2026 | 644.11M |
| August 07, 2026 | 650.10M |
| August 06, 2026 | 639.00M |
| August 05, 2026 | 639.00M |
| August 04, 2026 | 643.44M |
| July 31, 2026 | 644.55M |
| July 30, 2026 | 644.55M |
| July 29, 2026 | 653.10M |
| July 28, 2026 | 653.43M |
| July 27, 2026 | 655.65M |
| July 24, 2026 | 661.09M |
| July 23, 2026 | 655.65M |
| July 21, 2026 | 659.76M |
| July 20, 2026 | 658.65M |
| Date | Value |
|---|---|
| July 17, 2026 | 658.65M |
| July 16, 2026 | 657.54M |
| July 15, 2026 | 657.87M |
| July 14, 2026 | 657.54M |
| July 13, 2026 | 658.10M |
| July 10, 2026 | 656.54M |
| July 09, 2026 | 655.65M |
| July 08, 2026 | 644.55M |
| July 07, 2026 | 647.22M |
| July 06, 2026 | 641.78M |
| July 03, 2026 | 642.00M |
| July 02, 2026 | 642.00M |
| June 30, 2026 | 643.11M |
| June 29, 2026 | 581.12M |
| June 26, 2026 | 581.12M |
| June 25, 2026 | 571.95M |
| June 24, 2026 | 575.59M |
| June 23, 2026 | 581.12M |
| June 22, 2026 | 583.44M |
| June 19, 2026 | 590.73M |
| June 18, 2026 | 597.69M |
| June 17, 2026 | 597.69M |
| June 16, 2026 | 588.85M |
| June 15, 2026 | 586.64M |
| June 12, 2026 | 592.17M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Rhelion Life Sciences Corp. | 3.259M |
| TelyRx Holdings, Inc. | 62.81M |
| George Weston Ltd. | 63.74B |
| Loblaw Cos. Ltd. | 86.51B |
| Empire Co. Ltd. | 18.56B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 11.26M |
| Revenue (Quarterly) | 180.81M |
| Total Expenses (Quarterly) | 169.55M |
| EPS Diluted (Quarterly) | 0.465 |
| Gross Profit Margin (Quarterly) | 8.94% |
| Profit Margin (Quarterly) | 6.23% |
| Earnings Yield | 24.36% |
| Operating Earnings Yield | 7.22% |
| Normalized Earnings Yield | 6.460 |